MedTrace Logo

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

NCT01531452 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2014-12-04

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy and safety of oxaliplatin and s1 as first-line treatment of advanced gastric cancer.

Conditions

  • Stomach Neoplasms

Interventions

DRUG

Oxaliplatin

130mg/m2 d1,repeated q21d

DRUG

s1

80mg/m2/d, d1-14,repeated q21d

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Jinwan Wang, MD · cancer hospital&institute,Chinese Academy of Medical Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-11-30
Completion
2013-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01531452 on ClinicalTrials.gov